ArticleCancer medicine2022

The real-world clinical outcomes and treatment patterns of patients with unresectable locally advanced or metastatic soft tissue sarcoma treated with anlotinib in the post-ALTER0203 trial era.

Ren-Shu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.